Patients undergoing MSLT should have urine drug testing

A new study in the December 15 issue of the Journal of Clinical Sleep Medicine suggests drugs and substances are frequently found among patients being evaluated for hypersomnia and if undetected, may confound the MSLT results and the physician’s diagnosis. According to the authors, the results of this study support routine drug testing of patients undergoing assessment for a central hypersomnia.

Read the study in JCSM: Urine Toxicology in Adults Evaluated for a Central Hypersomnia and How the Results Modify the Physician’s Diagnosis